Objective
In vivo mechanism(s) of Et743 action are largely unknown. Some transcription factors, like NF-Y and SXR, are potential targets for the drug. Tidying their role on Cups regulation, we may achieve a breakthrough and avoid Et743-related side effects. In vivo mechanism(s) of Et743 action are largely unknown. Some transcription factors, like NF-Y and SXR, are potential targets for the drug. Studying their role on Cups regulation, we may achieve a breakthrough and avoid Et743-related side effects.
Call for proposal
Data not availableFunding Scheme
RGI - Research grants (individual fellowships)Coordinator
41100 MODENA
Italy